Samsung Biologics

207940.KO

1010.18 USD

2.25

+0.22%

Overview

Last close

1010.18 usd

Market cap

46.76B usd

52 week high

1154.38 usd

52 week low

655.09 usd

Target price

721.7 usd

Valuation

P/E

N/A

Forward P/E

35.5872

Price/Sales

12.6366

Price/Book Value

7.7281

Enterprise Value

45.94B usd

EV/Revenue

12.4288

EV/EBITDA

21.2622

Key financials

Revenue TTM

3.70B usd

Gross Profit TTM

2.00B usd

EBITDA TTM

2.04B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

8.18B usd

Net debt

437.33M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.